Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Genomic Health 09-060: A real-world observational study to provide prospective information on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) with disease progression after at least one line of androgen receptor-targeted therapy (ARTT) and the use of the Oncotype DX AR-V7 Nucleus Detect® assay in subsequent management
Principal Investigator
Co-Investigator(s)
Nitin Rohatgi, MD, Rajeswari Chellappah, M.D., Sivakumar Reddy, M.D., Kristin N. Arreola, M.D., Vijay Suhag, M.D., Kristie A. Bobolis, M.D., Brian K. Kim, M.D